ATRA
Atara Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.96
−2.40%Forward multiples
Based on analyst estimates
- P/E forward
- 11.50x
- P/E 2026E
- —
- P/E 2027E
- 9.74x
- P/E 2028E
- 20.96x
- P/S forward
- 2.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.43x
- Price / sales
- 14.52x
- Price / cash flow
- -4.11x
Enterprise value
- Enterprise value
- $89.9M
- EV / sales
- 14.52x
- EV / EBITDA
- -6.56x
- EV / EBIT
- -6.32x
- Market cap
- $89.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026